Re: Singh A et al . Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9

[1] on the safety and feasibility of robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in testicular cancer patients with postchemotherapy residual mass. [5] reported the overall incidence of chyle leak as 7% in O-RPLND for postchemotherapy residual mass. [...]the safety of RA-RPLND ca...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of urology 2018-01, Vol.34 (1), p.91-92
Main Authors: Temiz, Mustafa Zafer, Cakir, Omer Onur, Kandirali, Engin, Semercioz, Atilla
Format: Article
Language:English
Subjects:
Biopsy
Chemotherapy
Dissection
Letters to Editor
Lymphatic system
Robots
Testicular cancer
Urology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c544t-b086cbf1a3f1357eb4d3ff5d28940129eb8e248cfe44b058376f8e8038fb68933
container_end_page 92
container_issue 1
container_start_page 91
container_title Indian journal of urology
container_volume 34
creator Temiz, Mustafa Zafer
Cakir, Omer Onur
Kandirali, Engin
Semercioz, Atilla
description [1] on the safety and feasibility of robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in testicular cancer patients with postchemotherapy residual mass. [5] reported the overall incidence of chyle leak as 7% in O-RPLND for postchemotherapy residual mass. [...]the safety of RA-RPLND cannot be superior and we believe that the best inferences on safety and efficacy of RA-RPLND may be derived in a study comparing it with O-RPLND. Robot-assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor.
doi_str_mv 10.4103/iju.IJU_341_17
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c53077200c404d04a27bfa0750096f8b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A521408284</galeid><doaj_id>oai_doaj_org_article_c53077200c404d04a27bfa0750096f8b</doaj_id><sourcerecordid>A521408284</sourcerecordid><originalsourceid>FETCH-LOGICAL-c544t-b086cbf1a3f1357eb4d3ff5d28940129eb8e248cfe44b058376f8e8038fb68933</originalsourceid><addsrcrecordid>eNp9kkFrFDEYhgdRbK1ePUrAi5dZk0lmJlmhsBSrWwpCdc8hk_lmN8tMMiYZYX-Y_8-Mra0rRXIIJE-eL_nyZtlrgheMYPre7KfF-mojKSOS1E-yUyIEzykv2NPsFIsa56QU5CR7EcIeY0Z4UT3PTgpBWVmJ-jT7eQNL9NXY7Q6tEESkerRAN65xMVchmBChRR6idyN4E52FBPSHYdwh61pArQkBdDTOLtElqGAa05t4QMq2yE1RuwGQsWh0IeodDC7uwKvxkJTBtFNyDanKTEQI0eipVx5pZTX4BVrb1iiLrtDGux4VmNQfKF1SzHLxMnvWqT7Aq7v5LNtcfvx28Tm__vJpfbG6znXJWMwbzCvddETRjtCyhoa1tOvKtuCCYVIIaDgUjOsOGGtwyWlddRw4prxrKi4oPcvWt97Wqb0cvRmUP0injPy94PxWKp_u3YPUJcV1XWCsGWYtZqqom07husRYJGuTXOe3rnFqBmg12OhVfyQ93rFmJ7fuhyzrShQVS4J3dwLvvk-pX3IwQUPfKwtuCpIILtJfMzGjb_9B927yNrVqplhFGabVA7VV6QHGdi7V1bNUrsqCMMwLPrvyR6gt2PSTfQpEZ9LyEb94hE-jhcHo_x3Q3oXgobvvCcFyDrlMIZcPIU8H3vzdyXv8T6rpLyAu904</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1984634036</pqid></control><display><type>article</type><title>Re: Singh A et al . Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9</title><source>PubMed (Medline)</source><source>Medknow Open Access Medical Journals(OpenAccess)</source><source>ProQuest - Publicly Available Content Database</source><creator>Temiz, Mustafa Zafer ; Cakir, Omer Onur ; Kandirali, Engin ; Semercioz, Atilla</creator><creatorcontrib>Temiz, Mustafa Zafer ; Cakir, Omer Onur ; Kandirali, Engin ; Semercioz, Atilla</creatorcontrib><description>[1] on the safety and feasibility of robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in testicular cancer patients with postchemotherapy residual mass. [5] reported the overall incidence of chyle leak as 7% in O-RPLND for postchemotherapy residual mass. [...]the safety of RA-RPLND cannot be superior and we believe that the best inferences on safety and efficacy of RA-RPLND may be derived in a study comparing it with O-RPLND. Robot-assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor.</description><identifier>ISSN: 0970-1591</identifier><identifier>EISSN: 1998-3824</identifier><identifier>DOI: 10.4103/iju.IJU_341_17</identifier><identifier>PMID: 29345697</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Biopsy ; Chemotherapy ; Dissection ; Letters to Editor ; Lymphatic system ; Robots ; Testicular cancer ; Urology</subject><ispartof>Indian journal of urology, 2018-01, Vol.34 (1), p.91-92</ispartof><rights>COPYRIGHT 2018 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt. Ltd. Jan/Mar 2018</rights><rights>Copyright: © 2017 Indian Journal of Urology 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c544t-b086cbf1a3f1357eb4d3ff5d28940129eb8e248cfe44b058376f8e8038fb68933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1984634036/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1984634036?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,25753,27923,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29345697$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Temiz, Mustafa Zafer</creatorcontrib><creatorcontrib>Cakir, Omer Onur</creatorcontrib><creatorcontrib>Kandirali, Engin</creatorcontrib><creatorcontrib>Semercioz, Atilla</creatorcontrib><title>Re: Singh A et al . Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9</title><title>Indian journal of urology</title><addtitle>Indian J Urol</addtitle><description>[1] on the safety and feasibility of robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in testicular cancer patients with postchemotherapy residual mass. [5] reported the overall incidence of chyle leak as 7% in O-RPLND for postchemotherapy residual mass. [...]the safety of RA-RPLND cannot be superior and we believe that the best inferences on safety and efficacy of RA-RPLND may be derived in a study comparing it with O-RPLND. Robot-assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor.</description><subject>Biopsy</subject><subject>Chemotherapy</subject><subject>Dissection</subject><subject>Letters to Editor</subject><subject>Lymphatic system</subject><subject>Robots</subject><subject>Testicular cancer</subject><subject>Urology</subject><issn>0970-1591</issn><issn>1998-3824</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kkFrFDEYhgdRbK1ePUrAi5dZk0lmJlmhsBSrWwpCdc8hk_lmN8tMMiYZYX-Y_8-Mra0rRXIIJE-eL_nyZtlrgheMYPre7KfF-mojKSOS1E-yUyIEzykv2NPsFIsa56QU5CR7EcIeY0Z4UT3PTgpBWVmJ-jT7eQNL9NXY7Q6tEESkerRAN65xMVchmBChRR6idyN4E52FBPSHYdwh61pArQkBdDTOLtElqGAa05t4QMq2yE1RuwGQsWh0IeodDC7uwKvxkJTBtFNyDanKTEQI0eipVx5pZTX4BVrb1iiLrtDGux4VmNQfKF1SzHLxMnvWqT7Aq7v5LNtcfvx28Tm__vJpfbG6znXJWMwbzCvddETRjtCyhoa1tOvKtuCCYVIIaDgUjOsOGGtwyWlddRw4prxrKi4oPcvWt97Wqb0cvRmUP0injPy94PxWKp_u3YPUJcV1XWCsGWYtZqqom07husRYJGuTXOe3rnFqBmg12OhVfyQ93rFmJ7fuhyzrShQVS4J3dwLvvk-pX3IwQUPfKwtuCpIILtJfMzGjb_9B927yNrVqplhFGabVA7VV6QHGdi7V1bNUrsqCMMwLPrvyR6gt2PSTfQpEZ9LyEb94hE-jhcHo_x3Q3oXgobvvCcFyDrlMIZcPIU8H3vzdyXv8T6rpLyAu904</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Temiz, Mustafa Zafer</creator><creator>Cakir, Omer Onur</creator><creator>Kandirali, Engin</creator><creator>Semercioz, Atilla</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><general>Wolters Kluwer Medknow Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>201801</creationdate><title>Re: Singh A et al . Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9</title><author>Temiz, Mustafa Zafer ; Cakir, Omer Onur ; Kandirali, Engin ; Semercioz, Atilla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c544t-b086cbf1a3f1357eb4d3ff5d28940129eb8e248cfe44b058376f8e8038fb68933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Biopsy</topic><topic>Chemotherapy</topic><topic>Dissection</topic><topic>Letters to Editor</topic><topic>Lymphatic system</topic><topic>Robots</topic><topic>Testicular cancer</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Temiz, Mustafa Zafer</creatorcontrib><creatorcontrib>Cakir, Omer Onur</creatorcontrib><creatorcontrib>Kandirali, Engin</creatorcontrib><creatorcontrib>Semercioz, Atilla</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Indian journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Temiz, Mustafa Zafer</au><au>Cakir, Omer Onur</au><au>Kandirali, Engin</au><au>Semercioz, Atilla</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Re: Singh A et al . Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9</atitle><jtitle>Indian journal of urology</jtitle><addtitle>Indian J Urol</addtitle><date>2018-01</date><risdate>2018</risdate><volume>34</volume><issue>1</issue><spage>91</spage><epage>92</epage><pages>91-92</pages><issn>0970-1591</issn><eissn>1998-3824</eissn><abstract>[1] on the safety and feasibility of robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in testicular cancer patients with postchemotherapy residual mass. [5] reported the overall incidence of chyle leak as 7% in O-RPLND for postchemotherapy residual mass. [...]the safety of RA-RPLND cannot be superior and we believe that the best inferences on safety and efficacy of RA-RPLND may be derived in a study comparing it with O-RPLND. Robot-assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>29345697</pmid><doi>10.4103/iju.IJU_341_17</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0970-1591
ispartof Indian journal of urology, 2018-01, Vol.34 (1), p.91-92
issn 0970-1591
1998-3824
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c53077200c404d04a27bfa0750096f8b
source PubMed (Medline); Medknow Open Access Medical Journals(OpenAccess); ProQuest - Publicly Available Content Database
subjects Biopsy
Chemotherapy
Dissection
Letters to Editor
Lymphatic system
Robots
Testicular cancer
Urology
title Re: Singh A et al . Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer. Indian J Urol 2017;33:304-9
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A03%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Re:%20Singh%20A%20et%20al%20.%20Robot-assisted%20retroperitoneal%20lymph%20node%20dissection:%20Feasibility%20and%20outcome%20in%20postchemotherapy%20residual%20mass%20in%20testicular%20cancer.%20Indian%20J%20Urol%202017;33:304-9&rft.jtitle=Indian%20journal%20of%20urology&rft.au=Temiz,%20Mustafa%20Zafer&rft.date=2018-01&rft.volume=34&rft.issue=1&rft.spage=91&rft.epage=92&rft.pages=91-92&rft.issn=0970-1591&rft.eissn=1998-3824&rft_id=info:doi/10.4103/iju.IJU_341_17&rft_dat=%3Cgale_doaj_%3EA521408284%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c544t-b086cbf1a3f1357eb4d3ff5d28940129eb8e248cfe44b058376f8e8038fb68933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1984634036&rft_id=info:pmid/29345697&rft_galeid=A521408284&rfr_iscdi=true